This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n4http://linked.opendata.cz/resource/drugbank/drug/DB07009/identifier/pubchem-substance/
n5http://linked.opendata.cz/resource/drugbank/drug/DB07009/identifier/drugbank/
n11http://bio2rdf.org/drugbank:
n13http://linked.opendata.cz/resource/drugbank/drug/DB07009/identifier/chemspider/
admshttp://www.w3.org/ns/adms#
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n7http://linked.opendata.cz/ontology/drugbank/
n8http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n6http://linked.opendata.cz/resource/drugbank/drug/DB07009/identifier/pdb/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07009/identifier/pubchem-compound/

Statements

Subject Item
n2:DB07009
rdf:type
n7:Drug
n7:group
experimental
owl:sameAs
n11:DB07009 n12:DB07009
dcterms:title
2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL
adms:identifier
n4:99443480 n5:DB07009 n6:338 n13:20120245 n14:5326827
n7:IUPAC-Name
n8:271B40A2-363D-11E5-9242-09173F13E4C5
n7:InChI
n8:271B40A8-363D-11E5-9242-09173F13E4C5
n7:Molecular-Formula
n8:271B40A7-363D-11E5-9242-09173F13E4C5
n7:Molecular-Weight
n8:271B40A4-363D-11E5-9242-09173F13E4C5
n7:Monoisotopic-Weight
n8:271B40A5-363D-11E5-9242-09173F13E4C5
n7:SMILES
n8:271B40A6-363D-11E5-9242-09173F13E4C5
n7:Water-Solubility
n8:271B40A0-363D-11E5-9242-09173F13E4C5
n7:logP
n8:271B409E-363D-11E5-9242-09173F13E4C5 n8:271B40A1-363D-11E5-9242-09173F13E4C5
n7:logS
n8:271B409F-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Acceptor-Count
n8:271B40AE-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Donor-Count
n8:271B40AF-363D-11E5-9242-09173F13E4C5
n7:InChIKey
n8:271B40A9-363D-11E5-9242-09173F13E4C5
n7:Polar-Surface-Area--PSA-
n8:271B40AA-363D-11E5-9242-09173F13E4C5
n7:Polarizability
n8:271B40AC-363D-11E5-9242-09173F13E4C5
n7:Refractivity
n8:271B40AB-363D-11E5-9242-09173F13E4C5
n7:Rotatable-Bond-Count
n8:271B40AD-363D-11E5-9242-09173F13E4C5
n7:Bioavailability
n8:271B40B4-363D-11E5-9242-09173F13E4C5
n7:Ghose-Filter
n8:271B40B6-363D-11E5-9242-09173F13E4C5
n7:MDDR-Like-Rule
n8:271B40B7-363D-11E5-9242-09173F13E4C5
n7:Number-of-Rings
n8:271B40B3-363D-11E5-9242-09173F13E4C5
n7:Physiological-Charge
n8:271B40B2-363D-11E5-9242-09173F13E4C5
n7:Rule-of-Five
n8:271B40B5-363D-11E5-9242-09173F13E4C5
n7:Traditional-IUPAC-Name
n8:271B40A3-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-acidic-
n8:271B40B0-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-basic-
n8:271B40B1-363D-11E5-9242-09173F13E4C5